Sientra Acquires Novel Fat Grafting Technology from AuraGen Aesthetics LLC

Sientra Inc has entered into a definitive agreement to acquire substantially all of the assets related to AuraGen Aesthetics LLC’s novel fat grafting technology, the AuraGen 1-2-3 with AuraClens (the AuraGen system).